Evidence map›Paper›PMID 36973342›Full record

ArticleScientific reports2023

Facile preparation of a cost-effective platform based on ZnFe

Fereshteh Vajhadin, Mohammad Mazloum-Ardakani, Mahdie Hemati, Seyed Mohammad Moshtaghioun

Open access · goldFull text read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Fereshteh VajhadinDepartment of Chemistry, Faculty of Science, Yazd University, Yazd, 8915818411, Iran.
Mohammad Mazloum-ArdakaniDepartment of Chemistry, Faculty of Science, Yazd University, Yazd, 8915818411, Iran. mazloum@yazd.ac.ir.
Mahdie HematiDepartment of Clinical Biochemistry, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Seyed Mohammad MoshtaghiounDepartment of Biology, Faculty of Science, Yazd University, Yazd, Iran.
Yazd University · IRShahid Sadoughi University of Medical Sciences and Health Services · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Circulating tumor cells (CTCs) are important tumor markers that indicate early metastasis, tumor recurrence, and treatment efficacy. To identify and separate these cells from the blood, new nanomaterials need to be developed. The present study explored the potential application of ZnFe

Indexed as

Biosensing TechniquesNanoparticlesBiomarkers, TumorCarbonCost-Benefit AnalysisElectrochemical TechniquesHumansNeoplasm Recurrence, LocalBiomarkers, TumorCarbon

Identifiers

PMID36973342
PMCPMC10042879
OpenAlexW4361005678

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read58
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.